Gaps and overlaps: improving the current regulation of stem cells in the UK

A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK’s attempts to become a global leader in this fieldStem cells are the source cells in the human body fro...

Full description

Saved in:  
Bibliographic Details
Format: Electronic Article
Language:English
Check availability: HBZ Gateway
Journals Online & Print:
Drawer...
Fernleihe:Fernleihe für die Fachinformationsdienste
Published: BMJ Publ. 2007
In: Journal of medical ethics
Year: 2007, Volume: 33, Issue: 11, Pages: 621-622
Online Access: Presumably Free Access
Volltext (JSTOR)
Volltext (lizenzpflichtig)
Volltext (lizenzpflichtig)

MARC

LEADER 00000naa a22000002 4500
001 1816133523
003 DE-627
005 20220908053444.0
007 cr uuu---uuuuu
008 220908s2007 xx |||||o 00| ||eng c
024 7 |a 10.1136/jme.2007.022657  |2 doi 
035 |a (DE-627)1816133523 
035 |a (DE-599)KXP1816133523 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 1  |2 ssgn 
245 1 0 |a Gaps and overlaps: improving the current regulation of stem cells in the UK 
264 1 |c 2007 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
520 |a A failure to provide a comprehensive and cohesive regulatory system to govern stem cell research and application will hinder the development of treatments for serious diseases and undermine the UK’s attempts to become a global leader in this fieldStem cells are the source cells in the human body from which all other cells develop and have the remarkable ability to heal damaged tissue and to grow new tissue and, potentially, organs. In the UK, researchers are striving to harness these capacities to develop stem cell therapies for conditions such as macular degeneration, liver disease, infertility, spinal cord injury, Parkinson disease, diabetes and many more. The government is keen to ensure the UK’s global pre-eminence in this area, and in May 2004, £16.5 million of public sector funding was allocated to stem cell research.1 In 2005, the UK Stem Cell Initiative (UKSCI) was established to develop a 10-year research and development strategy for 2006 to 2016, aiming to ensure that the UK is “the most scientifically and commercially productive location for this activity over the coming decade, and which commands the support of public and private research funders, practitioners and commercial partners”.2 The UKSCI has recommended that the government should provide increased funding of £11 million to £74 million a year over the 10 years to 2016 and set up public/private partnerships to coordinate and develop stem cell research and technology.2To match the pace of scientific progress in stem cell research,3 4 it is critical that UK law is clear, consistent and capable of application by those working in the field, from the moment of obtaining tissues from which stem cells will be derived to their use in clinical applications. Unfortunately, this is far from the case. A plethora of legislation and other guidance, both … 
773 0 8 |i Enthalten in  |t Journal of medical ethics  |d London : BMJ Publ., 1975  |g 33(2007), 11, Seite 621-622  |h Online-Ressource  |w (DE-627)323607802  |w (DE-600)2026397-1  |w (DE-576)260773972  |x 1473-4257  |7 nnns 
773 1 8 |g volume:33  |g year:2007  |g number:11  |g pages:621-622 
856 |3 Volltext  |u http://www.jstor.org/stable/27719967  |x JSTOR 
856 |u https://europepmc.org/articles/pmc2598104?pdf=render  |x unpaywall  |z Vermutlich kostenfreier Zugang  |h repository [oa repository (via OAI-PMH doi match)] 
856 4 0 |u https://doi.org/10.1136/jme.2007.022657  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://jme.bmj.com/content/33/11/621.abstract  |x Verlag  |z lizenzpflichtig  |3 Volltext 
935 |a mteo 
951 |a AR 
ELC |a 1 
ITA |a 1  |t 1 
LOK |0 000 xxxxxcx a22 zn 4500 
LOK |0 001 4185587384 
LOK |0 003 DE-627 
LOK |0 004 1816133523 
LOK |0 005 20220908053444 
LOK |0 008 220908||||||||||||||||ger||||||| 
LOK |0 035   |a (DE-Tue135)IxTheo#2022-08-02#8B1C9B295828D2770D98EE4902A4B938C6C9EEED 
LOK |0 040   |a DE-Tue135  |c DE-627  |d DE-Tue135 
LOK |0 092   |o n 
LOK |0 852   |a DE-Tue135 
LOK |0 852 1  |9 00 
LOK |0 866   |x JSTOR#http://www.jstor.org/stable/27719967 
LOK |0 935   |a ixzs  |a ixrk  |a zota 
OAS |a 1 
ORI |a SA-MARC-ixtheoa001.raw